Jennifer Isacoff McNealey - 13 May 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Director
Signature
/s/ Jennifer Isacoff McNealey
Issuer symbol
CDT
Transactions as of
13 May 2024
Net transactions value
-$358,150
Form type
4
Filing time
15 May 2024, 16:30:47 UTC
Previous filing
05 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDT Stock Option (Right to Buy) Disposed to Issuer $358,150 -65,000 -100% $5.51 0 13 May 2024 Common Stock 65,000 $5.51 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jennifer Isacoff McNealey is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents Options to purchase common stock, granted under the Company's 2023 Stock Incentive Plan.
F2 The stock options were granted with a ten-year term and vest 33.3% on each of the first three anniversaries of the vesting commencement date, which is September 22, 2023.